颅内脑电图中高频振荡区完全切除对癫痫手术预后的价值:系统综述与Meta分析
该系统综述与Meta分析纳入31项研究共703例患者,评估颅内脑电图中高频振荡区完全切除(crHFOs-area)对癫痫手术良好预后(FSO)的预测价值。完全切除快涟漪区后FSO比例为81%(95%CI 76%-86%),涟漪区为82%(73%-89%);crHFOs-area患者较未完全切除者更常达到FSO(快涟漪区OR 6.38,95%CI 4.03-10.09,p<0.001;涟漪区OR 4.04,95%CI 2.32-7.04,p<0.001)。
要点
- 完全切除高频振荡区与癫痫手术良好预后相关,快涟漪区预测价值尤为突出。
- 快涟漪区完全切除后FSO比例为81%,涟漪区为82%,合并AUC分别为0.81和0.76。
- 颞叶癫痫患者完全切除快涟漪区后达到FSO的比例低于颞叶外癫痫(OR 0.37,95%CI 0.15-0.89,p=0.006)。
核心结论
- 完全切除高频振荡脑区与癫痫手术后良好预后相关,其预测价值在多个亚组中得以保持,尤其对快涟漪区。
- 将高频振荡用于颞叶外癫痫患者仍需进一步证据。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase和Web of Science从建库至2022年10月27日的原始研究。
- 共筛选1387项研究,最终纳入31项研究、703例患者;其中27项研究(602例患者)分析快涟漪区,20项研究(424例患者)分析涟漪区。
- 良好手术预后定义为Engel I级、国际抗癫痫联盟1级或癫痫无发作状态。
主要发现
- 完全切除快涟漪区后FSO合并比例为81%(95%CI 76%-86%),完全切除涟漪区后为82%(95%CI 73%-89%)。
- 完全切除高频振荡区患者较未完全切除者更常达到FSO:快涟漪区OR 6.38(95%CI 4.03-10.09,p<0.001),涟漪区OR 4.04(95%CI 2.32-7.04,p<0.001)。
- 合并AUC快涟漪区为0.81(95%CI 0.77-0.84),涟漪区为0.76(95%CI 0.72-0.79)。
- 颞叶癫痫患者完全切除快涟漪区后达到FSO的比例低于颞叶外癫痫患者(OR 0.37,95%CI 0.15-0.89,p=0.006)。
- 个体患者分析显示,在达到FSO的患者中,有MRI病灶者完全切除快涟漪区的情况多于无MRI病灶者(多重校正后p=0.02)。
关键数值与推荐
- 高合并预测价值定义为FSO比例>80% + crHFOs-area组FSO高于未crHFOs-area组 + AUC>0.75。
- 高合并预测价值见于10个亚组:回顾性研究、儿童、长期颅内脑电图、阈值设定(快涟漪区和涟漪区)、自动检测和发作间期(快涟漪区)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: High-frequency oscillations (HFOs; ripples 80-250 Hz; fast ripples [FRs] 250-500 Hz) recorded with intracranial electrodes generated excitement and debate about their potential to localize epileptogenic foci. We performed a systematic review and meta-analysis on the prognostic value of complete resection of the HFOs-area (crHFOs-area) for epilepsy surgical outcome in intracranial EEG (iEEG) accessing multiple subgroups. METHODS: We searched PubMed, Embase, and Web of Science for original research from inception to October 27, 2022. We defined favorable surgical outcome (FSO) as Engel class I, International League Against Epilepsy class 1, or seizure-free status. The prognostic value of crHFOs-area for FSO was assessed by (1) the pooled FSO proportion after crHFOs-area; (2) FSO for crHFOs-area vs without crHFOs-area; and (3) the predictive performance. We defined high combined prognostic value as FSO proportion >80% + FSO crHFOs-area >without crHFOs-area + area under the curve (AUC) >0.75 and examined this for the clinical subgroups (study design, age, diagnostic type, HFOs-identification method, HFOs-rate thresholding, and iEEG state). Temporal lobe epilepsy (TLE) was compared with extra-TLE through dichotomous variable analysis. Individual patient analysis was performed for sex, affected hemisphere, MRI findings, surgery location, and pathology. RESULTS: Of 1,387 studies screened, 31 studies (703 patients) met our eligibility criteria. Twenty-seven studies (602 patients) analyzed FRs and 20 studies (424 patients) ripples. Pooled FSO proportion after crHFOs-area was 81% (95% CI 76%-86%) for FRs and 82% (73%-89%) for ripples. Patients with crHFOs-area achieved more often FSO than those without crHFOs-area (FRs odds ratio [OR] 6.38, 4.03-10.09, p < 0.001; ripples 4.04, 2.32-7.04, p < 0.001). The pooled AUCs were 0.81 (0.77-0.84) for FRs and 0.76 (0.72-0.79) for ripples. Combined prognostic value was high in 10 subgroups: retrospective, children, long-term iEEG, threshold (FRs and ripples) and automated detection and interictal (FRs). FSO after complete resection of FRs-area (crFRs-area) was achieved less often in people with TLE than extra-TLE (OR 0.37, 0.15-0.89, p = 0.006). Individual patient analyses showed that crFRs-area was seen more in patients with FSO with than without MRI lesions (p = 0.02 after multiple correction). DISCUSSION: Complete resection of the brain area with HFOs is associated with good postsurgical outcome. Its prognostic value holds, especially for FRs, for various subgroups. The use of HFOs for extra-TLE patients requires further evidence.
引用
- Wang Z, Guo J, van 't Klooster M, et al. Prognostic Value of Complete Resection of the High-Frequency Oscillation Area in Intracranial EEG: A Systematic Review and Meta-Analysis. Neurology. 2024. PMID: 38560817. doi:10.1212/WNL.0000000000209216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。